Actinomycin D, C2 and VII, inhibitors of Grb2-SHC interaction produced by Streptomyces. 1998

J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
Korea Research Institute of Bioscience and Biotechnology, Taejon, Korea.

Actinomycin D, C2 and VII, cyclic peptides, inhibited Grb2 SH2 domain association (IC50 5-7 microM) with a phosphotyrosine containing peptide derived from the Shc protein (pTyr317). Actinomycins are the first examples of nonphosphorylated natural ligands of SH2 domain.

UI MeSH Term Description Entries
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016339 Spectrometry, Mass, Fast Atom Bombardment A mass spectrometric technique that is used for the analysis of a wide range of biomolecules, such as glycoalkaloids, glycoproteins, polysaccharides, and peptides. Positive and negative fast atom bombardment spectra are recorded on a mass spectrometer fitted with an atom gun with xenon as the customary beam. The mass spectra obtained contain molecular weight recognition as well as sequence information. Fast Atom Bombardment Mass Spectrometry,Fast Atom Bombardment Mass Spectroscopy,Mass Spectrometry, Fast Atom Bombardment,Mass Spectroscopy, Fast Atom Bombardment,Spectroscopy, Mass, Fast Atom Bombardment
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins
D051380 GRB2 Adaptor Protein A signal transducing adaptor protein that links extracellular signals to the MAP KINASE SIGNALING SYSTEM. Grb2 associates with activated EPIDERMAL GROWTH FACTOR RECEPTOR and PLATELET-DERIVED GROWTH FACTOR RECEPTORS via its SH2 DOMAIN. It also binds to and translocates the SON OF SEVENLESS PROTEINS through its SH3 DOMAINS to activate PROTO-ONCOGENE PROTEIN P21(RAS). Growth Factor Receptor-Bound Protein-2,Abundant Src Homology Protein,GRB2 Adaptor Protein, Grb3-3 Isoform,Grb3-3 Adaptor Protein,GRB2 Adaptor Protein, Grb3 3 Isoform,Growth Factor Receptor Bound Protein 2

Related Publications

J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
February 1995, Molecular and cellular biology,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
September 1995, Annals of the New York Academy of Sciences,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
January 1997, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
August 1964, Cancer research,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
March 1995, The Journal of antibiotics,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
July 2021, Scientific reports,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
April 1971, The Journal of antibiotics,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
July 2000, The Journal of antibiotics,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
April 2002, Molecular and cellular endocrinology,
J Y Nam, and H K Kim, and K H Son, and S U Kim, and B M Kwon, and M Y Han, and Y J Chung, and S H Bok
March 1995, The Journal of biological chemistry,
Copied contents to your clipboard!